The transcription factor Ndt80 does not contribute to Mrr1-, Tac1-, and Upc2-mediated fluconazole resistance in Candida albicans

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Sasse, Christoph ^a   Schillig, Rebecca ^a   Dierolf, Franziska ^a   Weyler, Michael ^a   Schneider, Sabrina ^a   Mogavero, Selene ^a,b   Rogers, P David ^c,d,e   Morschhäuser, Joachim ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF PISA   (Italy)

^c LE BONHEUR CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^e UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NDT80; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; FUNGAL PROTEIN; NDT80 PROTEIN, CANDIDA ALBICANS;

ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA ALBICANS; CDR1 GENE; CDR2 GENE; CONTROLLED STUDY; ERG GENE; FUNGAL STRAIN; FUNGUS ISOLATION; GENE; GENE FUNCTION; GENE MUTATION; GENE OVEREXPRESSION; GENE TARGETING; MRR1 GENE; NONHUMAN; TAC1 GENE; TRANSCRIPTION REGULATION; UPC2 GENE; UPREGULATION; ALLELE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

CANDIDA ALBICANS;

ALLELES; CANDIDA ALBICANS; DNA-BINDING PROTEINS; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 80053187522     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025623     Document Type: Article

References (36)

1. Morschhäuser J, (2002) The genetic basis of fluconazole resistance development in Candida albicans. Biochim Biophys Acta 1587: 240-248.
2. MacPherson S, Akache B, Weber S, De Deken X, Raymond M, et al. (2005) Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes. Antimicrob Agents Chemother 49: 1745-1752.
3. Silver PM, Oliver BG, White TC, (2004) Role of Candida albicans transcription factor Upc2p in drug resistance and sterol metabolism. Eukaryot Cell 3: 1391-1397.
4. Coste AT, Karababa M, Ischer F, Bille J, Sanglard D, (2004) TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2. Eukaryot Cell 3: 1639-1652.
5. Morschhäuser J, Barker KS, Liu TT, Blaß-Warmuth J, Homayouni R, et al. (2007) The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans. PLoS Pathog 3: e164.
6. Coste A, Selmecki A, Forche A, Diogo D, Bougnoux ME, et al. (2007) Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates. Eukaryot Cell 6: 1889-1904.
7. Coste A, Turner V, Ischer F, Morschhäuser J, Forche A, et al. (2006) A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans. Genetics 172: 2139-2156.
8. Coste AT, Crittin J, Bauser C, Rohde B, Sanglard D, (2009) Functional analysis of cis- and trans-acting elements of the Candida albicans CDR2 promoter with a novel promoter reporter system. Eukaryot Cell 8: 1250-1267.
9. Dunkel N, Blaß J, Rogers PD, Morschhäuser J, (2008) Mutations in the multi-drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole-resistant Candida albicans strains. Mol Microbiol 69: 827-840.
10. Dunkel N, Liu TT, Barker KS, Homayouni R, Morschhäuser J, et al. (2008) A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate. Eukaryot Cell 7: 1180-1190.
11. Heilmann CJ, Schneider S, Barker KS, Rogers PD, Morschhäuser J, (2010) An A643T mutation in the transcription factor Upc2p causes constitutive ERG11 upregulation and increased fluconazole resistance in Candida albicans. Antimicrob Agents Chemother 54: 353-359.
12. Hoot SJ, Smith AR, Brown RP, White TC, (2011) An A643V amino acid substitution in Upc2p contributes to azole resistance in well-characterized clinical isolates of Candida albicans. Antimicrob Agents Chemother 55: 940-942.
13. Schubert S, Rogers PD, Morschhäuser J, (2008) Gain-of-function mutations in the transcription factor MRR1 are responsible for overexpression of the MDR1 efflux pump in fluconazole-resistant Candida dubliniensis strains. Antimicrob Agents Chemother 52: 4274-4280.
14. Znaidi S, De Deken X, Weber S, Rigby T, Nantel A, et al. (2007) The zinc cluster transcription factor Tac1p regulates PDR16 expression in Candida albicans. Mol Microbiol 66: 440-452.
15. Sellam A, Askew C, Epp E, Tebbji F, Mullick A, et al. (2010) Role of transcription factor CaNdt80p in cell separation, hyphal growth, and virulence in Candida albicans. Eukaryot Cell 9: 634-644.
16. Sellam A, Tebbji F, Nantel A, (2009) Role of Ndt80p in sterol metabolism regulation and azole resistance in Candida albicans. Eukaryot Cell 8: 1174-1183.
17. Chen CG, Yang YL, Shih HI, Su CL, Lo HJ, (2004) CaNdt80 is involved in drug resistance in Candida albicans by regulating CDR1. Antimicrob Agents Chemother 48: 4505-4512.
18. Yang YL, Lin YH, Tsao MY, Chen CG, Shih HI, et al. (2006) Serum repressing efflux pump CDR1 in Candida albicans. BMC Mol Biol 7: 22.
19. De Backer MD, Ilyina T, Ma XJ, Vandoninck S, Luyten WH, et al. (2001) Genomic profiling of the response of Candida albicans to itraconazole treatment using a DNA microarray. Antimicrob Agents Chemother 45: 1660-1670.
20. Gupta V, Kohli A, Krishnamurthy S, Puri N, Aalamgeer SA, et al. (1998) Identification of polymorphic mutant alleles of CaMDR1, a major facilitator of Candida albicans which confers multidrug resistance, and its in vitro transcriptional activation. Curr Genet 34: 192-199.
21. Karababa M, Coste AT, Rognon B, Bille J, Sanglard D, (2004) Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters. Antimicrob Agents Chemother 48: 3064-3079.
22. Schubert S, Barker KS, Znaidi S, Schneider S, Dierolf F, et al. (2011) Regulation of efflux pump expression and drug resistance by the transcription factors Mrr1, Upc2, and Cap1 in Candida albicans. Antimicrob Agents Chemother 55: 2212-2223.
23. de Micheli M, Bille J, Schueller C, Sanglard D, (2002) A common drug-responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance. Mol Microbiol 43: 1197-1214.
24. Rognon B, Kozovska Z, Coste AT, Pardini G, Sanglard D, (2006) Identification of promoter elements responsible for the regulation of MDR1 from Candida albicans, a major facilitator transporter involved in azole resistance. Microbiology 152: 3701-3722.
25. Holmes AR, Lin YH, Niimi K, Lamping E, Keniya M, et al. (2008) ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates. Antimicrob Agents Chemother 52: 3851-3862.
26. Tsao S, Rahkhoodaee F, Raymond M, (2009) Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance. Antimicrob Agents Chemother 53: 1344-1352.
27. Znaidi S, Weber S, Al-Abdin OZ, Bomme P, Saidane S, et al. (2008) Genomewide location analysis of Candida albicans Upc2p, a regulator of sterol metabolism and azole drug resistance. Eukaryot Cell 7: 836-847.
28. Liu TT, Znaidi S, Barker KS, Xu L, Homayouni R, et al. (2007) Genome-wide expression and location analyses of the Candida albicans Tac1p regulon. Eukaryot Cell 6: 2122-2138.
29. Cannon RD, Lamping E, Holmes AR, Niimi K, Baret PV, et al. (2009) Efflux-mediated antifungal drug resistance. Clin Microbiol Rev 22: 291-321.
30. Goffeau A, (2008) Drug resistance: the fight against fungi. Nature 452: 541-542.
31. Reuß O, Vik Å, Kolter R, Morschhäuser J, (2004) The SAT1 flipper, an optimized tool for gene disruption in Candida albicans. Gene 341: 119-127.
32. Staib P, Kretschmar M, Nichterlein T, Hof H, Morschhäuser J, (2002) Transcriptional regulators Cph1p and Efg1p mediate activation of the Candida albicans virulence gene SAP5 during infection. Infect Immun 70: 921-927.
33. Ramírez-Zavala B, Reuß O, Park YN, Ohlsen K, Morschhäuser J, (2008) Environmental induction of white-opaque switching in Candida albicans. PLoS Pathog 4: e1000089.
34. Morschhäuser J, Michel S, Hacker J, (1998) Expression of a chromosomally integrated, single-copy GFP gene in Candida albicans, and its use as a reporter of gene regulation. Mol Gen Genet 257: 412-420.
35. Köhler GA, White TC, Agabian N, (1997) Overexpression of a cloned IMP dehydrogenase gene of Candida albicans confers resistance to the specific inhibitor mycophenolic acid. J Bacteriol 179: 2331-2338.
36. Ruhnke M, Eigler A, Tennagen I, Geiseler B, Engelmann E, et al. (1994) Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J Clin Microbiol 32: 2092-2098.